Clinical Cancer Research Versailles No Abst Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yeo, M.
Right arrow Articles by Hahm, K.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeo, M.
Right arrow Articles by Hahm, K.-B.
Clinical Cancer Research Vol. 10, 8687-8696, December 15, 2004
© 2004 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Selective Induction of Apoptosis with Proton Pump Inhibitor in Gastric Cancer Cells

Marie Yeo1, Dong-Kyu Kim1, Young-Bae Kim1, Tae Young Oh1, Jong-Eun Lee1, Sung Won Cho1, Hugh Chul Kim2 and Ki-Baik Hahm1

1 Genomic Research Center for Gastroenterology and 2 Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea

Purpose: To survive in an ischemic microenvironment with a lower extracellular pH, ability to up-regulate proton extrusion is critical for cancer cell survival. Gastric H+/K+-ATPase exchanges luminal K+ for cytoplasmic H+ and is the enzyme primarily responsible for gastric acidification. On the basis of the fact that blocking the clearance of acidic metabolites are known to induce the cell death, we hypothesized that pantoprazole (PPZ), one of gastric H+/K+-ATPase inhibitors used frequently to treat acid-related diseases, could inhibit growth of tumor cells.

Experimental Design: Genomic DNA fragmentation, terminal deoxynucleotidyl transferase (Tdt)-mediated nick end labeling assay, and annexin V staining were performed to detect PPZ-induced apoptosis. Mitogen-activated protein kinase activation and heat shock proteins expression were determined by immunoblot with specific antibodies. The antitumor effect of PPZ was evaluated in vivo by a xenograft model of nude mice.

Results: After PPZ treatment, apoptotic cell death was seen selectively in cancer cells and was accompanied with extracellular signal-regulated kinase deactivation. By contrast, normal gastric mucosal cells showed the resistance to PPZ-induced apoptosis through the overexpression of antiapoptotic regulators including HSP70 and HSP27. In a xenograft model of nude mice, administration of PPZ significantly inhibited tumorigenesis and induced large-scale apoptosis of tumor cells.

Conclusions: PPZ selectively induced in vivo and in vitro apoptotic cell death in gastric cancer, suggesting that proton pump inhibitors could be used for selective anticancer effects.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
H. K. Kim, W. S. Park, S. H. Kang, M. Warda, N. Kim, J.-H. Ko, A. E.-b. Prince, and J. Han
Mitochondrial alterations in human gastric carcinoma cell line
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C761 - C771.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Petrangolini, R. Supino, G. Pratesi, L. D. Bo, M. Tortoreto, A. C. Croce, P. Misiano, P. Belfiore, C. Farina, and F. Zunino
Effect of a Novel Vacuolar-H+-ATPase Inhibitor on Cell and Tumor Response to Camptothecins
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 939 - 946.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Yeo, D-K Kim, S U Han, J E Lee, Y B Kim, Y K Cho, J H Kim, S W Cho, and K-B Hahm
Novel action of gastric proton pump inhibitor on suppression of Helicobacter pylori induced angiogenesis
Gut, January 1, 2006; 55(1): 26 - 33.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.